Skip Navigation
  • The MHH
  • International office
  • Emergency numbers
  • Patients & Visitors
  • Facilities & Departments
    • Facilities & Departments
    • MHH Clinical departments
    • MHH-Institutes
    • Clinical departments and institutes sorted by center
    • Interdisciplinary centers
    • Central facilities
  • Research
    • Research
    • Research foci
      • Research foci
      • COVID-19
    • Core Research Units
      • Core Research Units
      • MeDIC
      • Hannover Unified Biobank (HUB)
      • Lasermikroskopie
      • Research Core Unit Electron Microscopy
    • Academic Career Development
    • Advisory Services
      • Advisory Services
      • DFG
    • Research Infrastructure
    • Dean of Research
    • Good Scientific Practice
      • Good Scientific Practice
      • Commission for Good Scientific Practice
      • Ombuds Office and Ombudsperson
    • Transparency in Research
    • Research Funding, Knowledge & Technology Transfer
      • Research Funding, Knowledge & Technology Transfer
      • Partners & Networks
      • For life scientists
      • For partners & investors
      • For startups and founders
  • Studying at MHH
    • Studying at MHH
    • All degree programs
    • Registrar's Office
      • Registrar's Office
      • Prospective students
      • Students
      • Dates & deadlines
      • Contact
  • Careers
Welcome to the MHH News
Searched for study. Found 119 results in 3 Millisekunden.

Filter by:

  • All content
  • Common content
  • Ambulances
  • News
  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • »
News

Top research in the fight against cancer

Relevance: 68%
 

BioNTech, with which he was or is associated as a member of the supervisory board. Christoph Huber studied medicine in Innsbruck, also completed his specialist training in internal medicine there and also [...] development of malignant tumours and are suitable as targets for targeted therapies. After her medical studies at the MHH and her basic science training as a post-doctoral researcher at Memorial Sloan-Kettering

News

Specialist for bone marrow diseases and cancer: Professor Heidel moves to the MHH

Relevance: 68%
 

working with the excellent team at my clinic and the proven experts at MHH." Florian Heidel had studied and obtained his doctorate in his native city of Erlangen before moving to Mainz for his specialist

News

MHH mourns the death of Professor Reinhold E. Schmidt

Relevance: 68%
 

Professor Dr Michael Manns. His enthusiasm for the immune system already gripped him during his medical studies in Bonn in the seventies. Professor Schmidt, who had been working at the MHH since 1980, headed the

News

The MHH mourns the death of Professor Karl-Martin Koch

Relevance: 68%
 

always honour his memory." Karl-Martin Koch was born in 1934 in Eschwege, Werra-Meißner district. He studied medicine in Göttingen, Würzburg and Frankfurt am Main. He acquired his specialisation as a clinical

News

Use in the pandemic is recognised for students after all

Relevance: 66%
 

that these services would be recognised as clinical traineeships or nursing internships in their studies. But this has not happened so far. The problem: Many of these internships had continued after the

News

Professor Christoph Garbers is the new director of the Institute of Clinical Biochemistry

Relevance: 63%
 

be able to link genuine basic biochemical research with translational application. "I originally studied pharmacy, and the development of substances that can ideally actually be used on patients one day

News

Success in the analysis of herpes viruses

Relevance: 63%
 

the resolution in this area of the capsid is not sufficient for this," explains Thomas Krey. In the study results now published, the researchers were able to prove that the portal cap protein (pORF19) also

News

Midwifery studies start at the MHH

Relevance: 63%
 

01.10.2021 The start has been a success: today, Friday, 28 students began their midwifery studies at the Hannover Medical School (MHH). Professor Dr. Mechthild Groß, head midwife and acting head of the

News

Drug combination triples survival time with blood cancer

Relevance: 61%
 

survival time of patients with newly diagnosed AML. This was the result of an international clinical study with the participation of Professor Dr. Michael Heuser, Senior Physician at the Department of Haematology

News

New therapeutic approach for bile duct cancer

Relevance: 61%
 

reasons for this and the strategies that can be used to overcome resistance to molecular treatment. The study has been published in the renowned journal "Hepatology". The first author is PhD student Gajanan Kendre

  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • »
Imprint Intranet Contact Privacy Accessibility
The MHH Hospital is a maximum care hospital with a nationwide catchment area. The university teaches medicine, dentistry, biochemistry, biomedicine, midwifery and health sciences. The main research areas are Transplantation and Stem Cell Research / Regenerative Medicine, Infection and Immunology Research, Biomedical Engineering and Implant Research.

   

Information about

Blood donation service MHH-Alumni e.V.

Follow us on

Facebook Instagram YouTube Xing LinkedIn
© 2019 - 2025 Medizinische Hochschule Hannover
Nach oben scrollen